Antiplatelet drugs

Cilostazol /sᵻˈlɒstəzɒl/ is a quinolinone-derivative medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease.

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.

Picotamide is a platelet aggregation inhibitor.

Terbogrel blocks thromboxanes and is expected to be useful in treating the vasoconstricting and platelet aggregating action of this compound.

Ditazole is a platelet aggregation inhibitor.

Cloricromen is a platelet aggregation inhibitor.

Ramatroban (INN) is a thromboxane receptor antagonist.

Terutroban is an antiplatelet agent developed by Servier Laboratories.

Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.

Dipyridamole (trademarked as Persantine) is a medication that inhibits blood clot formation when given chronically and causes blood vessel dilation when given at high doses over a short time.

Indobufen is a platelet aggregation inhibitor.

Clorindione is a vitamin K antagonist.

Carbasalate calcium is an analgesic, antipyretic, and anti-inflammatory drug, as well as a platelet aggregation inhibitor.